Detection of genomic rearrangements by sequence capture

• US 10,017,820 B2
• Filed: 03/05/2013
• Issued: 07/10/2018
• Est. Priority Date: 03/05/2013
• Status: Active Grant

• Current Assignee: Agilent Technologies, Inc.
• Original Assignee: Agilent Technologies, Inc.
• Inventors: Ruvolo, Michael, Leproust, Emily Marine
• Primary Examiner(s): Thomas, David C
• Application Number:
  US14/772,064
• Publication Number:
  US 20160017425A1
• Time in Patent Office: 1,953 Days
• Field of Search: None
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 1/683 involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
• CPC Class Codes: C12Q 1/6883 for diseases caused by alterations of genetic material
• CPC Class Codes: C12Q 2533/107 Probe or oligonucleotide ligation

Abstract

Provided herein is a method of sample analysis. In some embodiments, the method comprises hybridizing fragmented genomic DNA from a test genome with a population of first oligonucleotides of the formula V₁-B-V₂ in the presence of one or more second oligonucleotides; contacting the product with ligase to join the ends of the fragmented genomic DNA that are hybridized to V₁ and V₂ to the one or more second oligonucleotides; and subjecting the product to polymerase chain reaction conditions using amplification primers that hybridize to sites that are provided by the one or more second oligonucleotides, wherein production of a product indicates that the test genome contains a chromosomal rearrangement relative to the reference genome.

Claims

1. A method of sample analysis, comprising:

(a) hybridizing fragmented genomic DNA from a test genome with a population of first oligonucleotides of the formula V₁-B-V₂ in the presence of one or more second oligonucleotides;

wherein;

(i) the nucleic acid sequence B is the same for each of said first oligonucleotides and is at least 15 nucleotides in length;

(ii) the nucleic acid sequence V₁ is variable;

(iii) the nucleic acid sequence V₂ is variable;

(iv) within each first oligonucleotide, the V₁ and V₂ sequences hybridize to sites that are at least 10 kb apart in a reference genome; and

(v) said one or more second oligonucleotides hybridize to nucleic acid sequence B;

(b) contacting the product of (a) with ligase to join the ends of said fragmented genomic DNA that are hybridized to V₁ and V₂ to the one or more second oligonucleotides; and

(c) subjecting the product of (b) to polymerase chain reaction conditions using amplification primers that hybridize to sites that are provided by said one or more second oligonucleotides,

wherein production of a product by step (c) indicates that said test genome contains a chromosomal rearrangement relative to said reference genome.

2. The method of claim 1, further comprising sequencing the product of (c).

3. The method of claim 2, further comprising analyzing the sequence to identify the breakpoint for said chromosomal rearrangement.

4. The method of claim 1, wherein, within each first oligonucleotide, the V₁ and V₂ sequences hybridize to sites that are on different chromosome arms in the reference genome.

5. The method of claim 1, wherein, within each first oligonucleotide, the V₁ and V₂ sequences hybridize to sites that are on different chromosomes in the reference genome.

6. The method of claim 1, wherein said test and reference genomes are mammalian genomes from the same species.

7. The method of claim 1, wherein said fragmented genomic DNA is made by digesting genomic DNA using a restriction enzyme.

8. The method of claim 1, wherein said one or more second oligonucleotides are single oligonucleotides that hybridize to the nucleic acid sequence B of said first oligonucleotides.

9. The method of claim 1, wherein said one or more second oligonucleotides are two oligonucleotides, each comprising a first region that hybridizes to the nucleic acid sequence B of said first oligonucleotides, and a second region that provides a binding site for an amplification primer of (c).

10. The method of claim 1, wherein V₁ and V₂ are each at least 15 bases in length.

11. The method of claim 1, wherein said the V₁ sequences are tiled across a first region in said reference genome and the V₂ sequences are tiled across a second region in said reference genome.

12. The method of claim 1, wherein said test genome is suspected of containing a chromosomal rearrangement.

13. The method of claim 1, wherein said fragmented genomic DNA are polynucleotides having a length up to 10,000 bases.

14. The method of claim 1, wherein said fragmented genomic DNA has an average size in the range of 100 bp to 10 kb.

15. The method of claim 1, wherein said fragmented genomic DNA has an average size in the range of 200 bp to 1 kb.

16. The method of claim 1, wherein, within each first oligonucleotide, the V₁ and V₂ sequences hybridize to sites that are on the same chromosome.